Gentry Medical Center

CLIA Laboratory Citation Details

2
Total Citations
3
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 04D0468729
Address 643 East Third Street, Gentry, AR, 72734
City Gentry
State AR
Zip Code72734
Phone(479) 736-2213

Citation History (2 surveys)

Survey - January 15, 2020

Survey Type: Standard

Survey Event ID: VQ0J11

Deficiency Tags: D5413 D5415

Summary:

Summary Statement of Deficiencies D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Through observation, lack of documentation and interview it was determined the laboratory failed to monitor room temperature in two of three rooms in which supplies with storage temperature requirement were stored. Findings follow: A) During a tour of the laboratory on 1/15/20 at approximately 11:45 AM, 400 Vacuette SST blood collection tubes lot# B191133B expiration date 2021-05-05; 400 Vacuette EDTA blood collection tubes lot# B19063 VP expiration date 2020-10-12 all with a storage temperature requirement of 4 degrees C. to 25 degrees C. were observed stored in a storage room separate from the laboratory and 18 Vacuette SST blood collection tubes lot# B190838S expiration date 2021-02-06; 34 Vacuette EDTA blood collection tubes lot# B19053M expiration date 2020-09-12 and 80 BD SST blood collection tubes lot# 9213122 expiration date 2020-07-31 all with storage temperature requirement of 4 degrees C. to 25 degrees C. were observed in a phlebotomy room separate from the laboratory. . B) Upon request, the laboratory was unable to provide records of room temperature in the separate storage room or the phlebotomy room identified above. C) In an interview on 1/15/20 at approximately 11:45 AM, the laboratory staff member, identified as number two on the CMS 209 form, stated that the laboratory did not monitor the room temperatures in the storage and phlebotomy rooms identified above. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Through review of package insert for Boule Hematology quality controls, observation, and interview it was determined that the laboratory did not label the control vials with the date and time opened and placed into use, or an amended expiration date and time as required by the manufacturer. Findings follow: A) The manufacturer's package insert for Boule Heamatology controls state "once opened controls are stable in their original vials for 14 days if kept at 2 to 6 degrees C. ". B) During a tour of the laboratory on 1-15/20 at approximately 11:45, three of three vials of Boule Hematology controls lot #'s 21911-21, 21911-22, 21922-23 were observed in the refrigerator which were not labeled with the date and time that the controls were opened and placed in use or an amended expiration date. C) In an interview on 1/15 /20 at approximately 11:45 AM, the laboratory staff member, identified as number 2 on the CMS 209 form, confirmed that the vials of hematology controls identified above had not been labeled with the date opened and were currently in use. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - June 19, 2018

Survey Type: Standard

Survey Event ID: NSBJ11

Deficiency Tags: D5481

Summary:

Summary Statement of Deficiencies D5481 CONTROL PROCEDURES CFR(s): 493.1256(f)(g) (f) Results of control materials must meet the laboratory's and, as applicable, the manufacturer's test system criteria for acceptability before reporting patient test results. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Through a review of the QC (quality control) file tabular reports for November 2017, a review of the Tabular report for 11/1/2017 and 11/2/2017, and interviews with laboratory staff, it was determined the laboratory failed to ensure control results were acceptable before reporting patient test results. Survey findings follow: A. The QC file tabular reports for November include all hematology quality controls tested and also include the time that each control was run. On 11/1/2017 the QC file tabular reports include the QC Low which was tested at 16:12 (4:12 p.m.), the QC Normal which was tested at 16:18 (4:18 p.m.), and the QC High which was tested at 16:22 (4:22 p.m.). B. The Tabular report (a list of patients tested with the time that they were tested) for 11/1 /2017 includes eight patients. All eight patients were tested prior to the quality controls. Patient samples tested are as follows: 00916231 at 8:35 a.m.; 00916224 at 8: 37 a.m.; 00916240 at 8:39 a.m.; 00916297 at 11:01 a.m.; 00916271 at 11:45 a.m.; 00916324 at 11:48 a.m.; 00916303 at 11:52 a.m.; and 00916265 at 11:59 a.m. C. The QC file tabular reports for November include all hematology quality controls tested and also include the time that each control was run. On 11/2/2017 the QC file tabular reports include the QC Low which was tested at 16:03 (4:12 p.m.), the QC Normal which was tested at 16:05 (4:18 p.m.), and the QC High which was tested at 16:07 (4: 22 p.m.). D. The Tabular report for 11/2/2017 includes twelve patients. All twelve patients were tested prior to the quality controls. Patient samples tested are as follows: 00916446 at 8:52 a.m.; 00916481 at 9:31 a.m.; 00916492 at 9:49 a.m.; 00916460 at 10:13 a.m.; 00916465 at 10:32 a.m.; 00916446 at 10:35 a.m.; 00916511 at 10:41 a.m.; 00916549 at 11:18 a.m.; 00916558 at 11:42; 00916587 at 13:38; 00916614 at 14:53; Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- and 00916617 at 15:03. E. In an interview at 3:12 p.m. on 6/19/2018, the technical (as listed on the form CMS-209) confirmed the laboratory reported patients prior to testing quality control. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access